Indoco Remedies has informed that a meeting of the Board of Directors will be held on 30th May, 2018, to consider and take on record the unaudited financial results of the Company for the last quarter ended 31st March 2018; the audited financial results for the year ended 31st March, 2018 and recommendation of final dividend, if any, for the financial year 2017-2018. The 'Trading Window’ of the Company shall remain closed with effect from May 23, 2018, and shall end after 48 hours from the conclusion of the aforesaid Board Meeting.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: